## Clinical Description of GERD Without Esophagitis Gastro-esophageal reflux disease (GERD) without esophagitis, clinically referred to as Non-Erosive Reflux Disease (NERD), is a subcategory of GERD characterized by the presence of reflux-related symptoms—typically heartburn and regurgitation—in the absence of visible esophageal mucosal injury during an upper endoscopy (EGD). While the absence of erosive changes might suggest a milder form of the disease, patients with K21.9 often report symptom severity and impairment of quality of life comparable to those with erosive esophagitis. ### Pathophysiology The underlying mechanism of K21.9 involves the retrograde movement of gastric contents (acid, pepsin, and occasionally bile) into the esophagus. This is primarily driven by transient lower esophageal sphincter relaxations (TLESRs), a hypotensive lower esophageal sphincter (LES), or anatomical disruptions such as a hiatal hernia. In the case of NERD, the esophageal mucosa remains macroscopically intact, but microscopic changes—such as dilated intercellular spaces (DIS)—are often present. These changes increase mucosal permeability, allowing acid to reach and stimulate nociceptive nerve endings within the epithelium. Furthermore, visceral hypersensitivity plays a significant role in NERD, where the esophagus becomes overly sensitive to even physiological levels of acid or non-acid reflux. ### Diagnostic Criteria and Evaluation The diagnosis of K21.9 is primarily clinical, based on the frequency and nature of symptoms. However, to formally classify it under K21.9, an EGD must demonstrate the absence of mucosal breaks (Los Angeles Classification Grade A-D). For patients who do not respond to standard empiric therapy with Proton Pump Inhibitors (PPIs), further diagnostic testing such as 24-hour ambulatory pH monitoring or pH-impedance testing is warranted. These tests help differentiate NERD from functional heartburn (where symptoms occur without reflux) by establishing a temporal correlation between reflux events and symptoms. ### Standard of Care and Management Management of K21.9 mirrors that of erosive GERD but with a focus on symptom control rather than mucosal healing. The standard of care begins with lifestyle modifications: weight loss, elevation of the head of the bed, and the avoidance of late-night meals or trigger foods (e.g., caffeine, fatty foods, alcohol). Pharmacological intervention typically involves H2-receptor antagonists or PPIs. Because NERD patients may have higher rates of PPI resistance compared to those with erosive disease, optimizing dosage timing or switching to different acid-suppressive agents is common practice. Long-term surveillance focuses on monitoring for the development of complications, although the progression from NERD to Barrett's esophagus is less frequent than in erosive phenotypes.
Explicitly Document the Absence of Esophagitis to Support K21.9
Example: Patient presents with persistent post-prandial pyrosis and acid regurgitation. Recent EGD (05/12/2023) confirmed normal esophageal mucosa with no evidence of erosive esophagitis, ulceration, or Barrett's. Assessment: Gastro-esophageal reflux disease without esophagitis (K21.9). Plan: Continue PPI for symptom management of this chronic condition.
Billing Focus: Documentation must specify 'without esophagitis' to support K21.9; if esophagitis is present, K21.00 should be used instead.
Distinguish Between Simple Heartburn and Established GERD
Example: Patient reports daily substernal burning for 6 months, worsening at night. Symptoms are not transient or purely diet-induced but represent a chronic disease state. Diagnosis: Chronic gastro-esophageal reflux disease without esophagitis (K21.9). This is distinct from R12 (Heartburn), which describes a symptom rather than a confirmed disease process.
Billing Focus: Use K21.9 for a definitive diagnosis of the disease process; use R12 only if a definitive diagnosis of GERD has not yet been established.
Link GERD to Relevant Extra-esophageal Manifestations
Example: Patient with known chronic GERD (K21.9) presents with nocturnal cough and hoarseness. Pulmonology evaluation suggests GERD is the primary trigger for the patient's reactive airway symptoms. GERD is managed with high-dose H2 blockers and lifestyle changes. Current status: GERD without esophagitis, symptomatic with extra-esophageal cough.
Billing Focus: Documentation of extra-esophageal symptoms like cough (R05.3) or laryngitis (J04.0) should be linked to K21.9 to demonstrate complexity.
Document Long-term Medication Use and Response
Example: 65-year-old male with long-standing GERD without esophagitis (K21.9). Patient is dependent on daily Pantoprazole 40mg (Z79.899) for symptom control. Without medication, patient experiences severe retrosternal pain interfering with sleep. Condition is stable on current regimen but requires ongoing monitoring for PPI-related side effects.
Billing Focus: Include Z79.899 (Long term current use of other medications) to support the ongoing management of K21.9.
Clarify Anatomical Triggers such as Hiatal Hernia
Example: Patient with GERD without esophagitis (K21.9) and a known sliding hiatal hernia (K44.9). The hernia contributes to the mechanical failure of the LES, necessitating surgical consultation for possible Nissen fundoplication due to refractory symptoms despite maximal medical therapy.
Billing Focus: Document both K21.9 and K44.9 if both are present, as the hernia provides anatomical specificity for the cause of the reflux.
Standard for a follow-up of stable GERD where one chronic problem is addressed.
Applicable when GERD is poorly controlled, requiring a change in treatment plan or coordination with specialists.
Used to confirm the absence of esophagitis or check for Barrett's esophagus.
The gold standard for diagnosing GERD when endoscopy is negative.
Used for 48-hour pH monitoring to correlate symptoms with reflux events.
Assesses LES function and esophageal clearance in patients considering surgery for GERD.
Initial evaluation of a new patient presenting with classic reflux symptoms.
Initial visualization of the upper GI tract to rule out structural causes for reflux.
Surgical treatment for GERD that is refractory to medical management.
Used to identify hiatal hernias or esophageal strictures associated with GERD.